SK
Sarada Kalyani Bhagawati
About Sarada Kalyani Bhagawati
Data last updated:
Sarada Kalyani Bhagawati is a Whole-Time Director at Mylan Laboratories Limited (since 2014). The companies operate in Pharma. Mylan Laboratories Limited reported revenue of ₹7,504 Cr (FY 2025). Earlier, Sarada Kalyani Bhagawati was an Additional Director at Tianish Laboratories Private Limited (2024) and Additional Director at Senador Laboratories Private Limited (2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mylan Laboratories Limited U24231TG1984PLC005146 | Whole-Time Director | 01 Nov 2014 | 1984 | ₹7,504 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tianish Laboratories Private Limited U21001TS2023PTC171372 | Additional Director | 28 Feb 2024 | 2023 | ₹2,060 Cr (FY 2024) | Amalgamated |
| Senador Laboratories Private Limited U21001TS2023PTC171514 | Additional Director | 16 Feb 2024 | 2023 | ₹29.13 Cr (FY 2024) | Active |
 Mylan Pharmaceuticals Private Limited U73100TG1997PTC149781 | Director | 16 Aug 2013 | 1997 | ₹1,253 Cr (FY 2025) | Active |
| Madaus Pharmaceuticals Private Limited U24230TG1996PTC124476 | Director | 15 Sep 2017 | 1996 | ₹71.81 Cr (FY 2018) | Amalgamated |
| Astrix Laboratories Limited U24239TG2005PLC047551 | Director | 19 May 2009 | 2005 | Amalgamated | |
 Jai Pharma Limited U74999MH2015PLC262055 | Additional Director | 20 Nov 2015 | 2015 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sarada Kalyani Bhagawati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akshay Nanda | 10517236 | Mylan Laboratories Limited | Director |
| Arvind Shankar Kanda | 10560284 | Mylan Laboratories Limited | Whole-Time Director |
| Nagaraj Goud Bodige | Mylan Laboratories Limited | Company Secretary | |
| Nagaraj Goud Bodige | 10329289 | Mylan Laboratories Limited | Nodal Officer |
| Rajiv Malik | 00120557 | Mylan Laboratories Limited | Director |
| Ramya Suresh | 10603923 | Mylan Laboratories Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarada Kalyani Bhagawati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarada Kalyani Bhagawati
Sarada Kalyani Bhagawati currently holds 1 directorship: Mylan Laboratories Limited (Whole-Time Director, since 01 Nov 2014, revenue ₹7,504 Cr (FY 2025)).
Sarada Kalyani Bhagawati was first appointed on 19 May 2009 as Director at Astrix Laboratories Limited. The most recent appointment on record is 28 Feb 2024 at Tianish Laboratories Private Limited.
Sarada Kalyani Bhagawati held 6 earlier board appointments: Tianish Laboratories Private Limited (Additional Director, 28 Feb 2024 to 03 Jun 2024); Senador Laboratories Private Limited (Additional Director, 16 Feb 2024 to 12 Mar 2024); Mylan Pharmaceuticals Private Limited (Director, 16 Aug 2013 to 01 Nov 2014); Madaus Pharmaceuticals Private Limited (Director, from 15 Sep 2017); Astrix Laboratories Limited (Director, from 19 May 2009); and 1 more.
The current boards of Sarada Kalyani Bhagawati's companies include Akshay Nanda (Mylan Laboratories Limited), Arvind Shankar Kanda (Mylan Laboratories Limited), Nagaraj Goud Bodige (Mylan Laboratories Limited), Nagaraj Goud Bodige (Mylan Laboratories Limited), Rajiv Malik (Mylan Laboratories Limited), Ramya Suresh (Mylan Laboratories Limited).